10 Grants
2021
Elucidation of molecular mechanisms of prenatal cannabinoid exposure: Identification of targets and therapies
Reed, Miranda N and SUPPIRAMANIAM, VISHNU D
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA046723-02), $290,671USD, 2020-04-15 -- 2025-02-28
2020
Elucidation of molecular mechanisms of prenatal cannabinoid exposure: Identification of targets and therapies
Reed, Miranda N and SUPPIRAMANIAM, VISHNU D
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R01DA046723-01A1), $352,843USD, 2020-04-15 -- 2025-02-28
2015
Novel PPAR-gamma agonist selectively activate the ligand binding domain of PPAR-gamma and improve pathology and memory deficits in a 3xTg-Ad mouse model.
Amin, Rajesh H and SUPPIRAMANIAM, VISHNU D
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1R15AG048643-01A1), $361,955USD, 09/01/2015 -- 08/31/2018
2002
Modulation of Glutamate AMPA Receptor by Polysialic Acid
SUPPIRAMANIAM, VISHNU D
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 2S06GM008091-31), 06/01/1978 -- 06/30/2006
2001
MODULATION AND CHARACTERIZATION OF GLUTAMATE (AMPA) RECEPTORS
SUPPIRAMANIAM, VISHNU D
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5S06GM008091-30), $109,973USD, 06/01/2001 -- 09/04/2002
2000
MODULATION AND CHARACTERIZATION OF GLUTAMATE (AMPA) RECEPTORS
SUPPIRAMANIAM, VISHNU D
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 3S06GM008091-29S1), $109,973USD, 06/01/2000 -- 05/31/2001
 
MODULATION AND CHARACTERIZATION OF GLUTAMATE (AMPA) RECEPTORS
SUPPIRAMANIAM, VISHNU D
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5S06GM008091-29), $30,384USD, 06/01/2000 -- 05/31/2001
 
MODULATION AND CHARACTERIZATION OF GLUTAMATE (AMPA) RECEPTORS
SUPPIRAMANIAM, VISHNU D
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 3S06GM008091-28S1), $30,384USD, 06/01/1999 -- 05/31/2000
1999
MODULATION AND CHARACTERIZATION OF GLUTAMATE (AMPA) RECEPTORS
SUPPIRAMANIAM, VISHNU D
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5S06GM008091-28), 06/01/1999 -- 05/31/2000
1998
MODULATION AND CHARACTERIZATION OF GLUTAMATE (AMPA) RECEPTORS
SUPPIRAMANIAM, VISHNU D
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 2S06GM008091-27), 08/01/1998 -- 05/31/1999